Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

More Patient Registries Needed To Facilitate CER, Medco Exec Says

Executive Summary

Comparative effectiveness research could benefit from broader use of registries of patients using particular drugs, Medco Research Institute President Felix Frueh said.

You may also be interested in...



Linking EHRs To Cancer Registries Good In Theory, But Difficult In Practice, ASCO Says

The American Society of Clinical Oncology offers support for the notion of using electronic health records to help provide information to cancer registries, but is critical of CMS’ approach as outlined in the stage 2 meaningful use proposed rule.

PCORI Board Eyes Connection Between Health IT Meaningful Use And Comparative Effectiveness Research

Members at the Patient-Centered Outcomes Research Institute's inaugural meeting agree they should bring in HHS health IT office head to discuss intersection between electronic health records and CER.

Antipsychotic Drugs Are Medco's New Personalized Medicine Target

Medco will launch a research project in November that aims to validate a biomarker that may improve the cost effectiveness of atypical antipsychotics. The pharmacy benefit manager announced a research collaboration with development-stage genetic test developer SureGene on Aug. 24

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS052964

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel